BH3 mimetic drugs for prostate cancer therapy

Ended Project Grant Awarded Last action

Award ID
W81XWH2110471
Recipient
Awarding agency
Obligated
$1,274,833

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Place of performance
Boston, MA 02215, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment (no IDC) BH3-mimetic drugs for prostate cancer therapy 1. Deobligates $37,667.21 in accordance with the SF425 dated 2/12/2026. The total award amount has been… -$37,667
Original award $1,312,500

Quick answers

Who received award W81XWH2110471?

W81XWH2110471 was awarded to Beth Israel Deaconess Medical Center, Inc. by Defense Health Agency (Department of Defense) on July 1, 2021.

How much is award W81XWH2110471 worth?

$1,274,833 has been obligated on W81XWH2110471.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login